Telomir Pharmaceuticals, Inc. Proceeds from (Repayments of) Related Party Debt
Telomir Pharmaceuticals, Inc. (TELO) reported Proceeds from (Repayments of) Related Party Debt of -$433.94 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-17.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt · last filed 2026-03-17
- Telomir Pharmaceuticals, Inc. proceeds from (repayments of) related party debt for the quarter ending 2024-12-31 was $1.00, a 100.00% decline year-over-year.
- Telomir Pharmaceuticals, Inc. proceeds from (repayments of) related party debt for the quarter ending 2023-12-31 was $951.88K.
- Telomir Pharmaceuticals, Inc. proceeds from (repayments of) related party debt for fiscal 2024 was -$433.94K, a 126.09% decline from fiscal 2023.
- Telomir Pharmaceuticals, Inc. proceeds from (repayments of) related party debt for fiscal 2023 was $1.66M, a 259.69% increase from fiscal 2022.
- Telomir Pharmaceuticals, Inc. proceeds from (repayments of) related party debt for fiscal 2022 was $462.39K.
| Period end | Proceeds from (Repayments of) Related Party Debt | Proceeds from (Repayments of) Related Party Debt 3 month | Proceeds from (Repayments of) Related Party Debt 9 month | Proceeds from (Repayments of) Related Party Debt 12 month | Proceeds from (Repayments of) Related Party Debt 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | $1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | -$433.94K 10-K · filed 2026-03-17 | |||
| 2024-09-30 | -$433.95K 10-Q · filed 2024-11-12 | ||||
| 2023-12-31 | $951.88K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-04 | $1.66M 10-K · filed 2025-02-04 | -$54.41K 10-K · filed 2024-03-29 | ||
| 2023-11-30 | $3.10M 10-K · filed 2025-02-04 | ||||
| 2023-09-30 | $711.28K 10-Q · filed 2024-11-12 | ||||
| 2022-12-31 | $462.39K 10-K · filed 2024-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |